Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jan Grøndahl-Hansen"'
Autor:
Vibeke Sørensen, Kristen Barfod, Lars Andresen, Joan Klausen, Jan Grøndahl-Hansen, Peter M. H. Heegaard
Publikováno v:
Veterinary Microbiology. 96:41-51
The objective was to develop an enzyme-linked immunosorbent assay (ELISA) for simultaneous detection of antibodies against Actinobacillus pleuropneumoniae (Ap) serotypes 2, 6 and 12. The assay was designated MIX-ELISA. Lipopolysaccharide (LPS) from A
Autor:
Stelios Kakolyris, Marian Taylor, Stephen B. Fox, Jan Grøndahl-Hansen, Adrian L. Harris, Kevin C. Gatter
Publikováno v:
The Journal of Pathology. 195:236-243
The generation of urokinase plasminogen activator (uPA) by tumours is an important pathway for neoplastic cell invasion and metastasis. Indeed in several tumour types, elevated levels of uPA, its receptor (uPAR) or its inhibitor plasminogen activator
Publikováno v:
Lung Cancer. 17:197-209
The components of the plasminogen activation system have been reported to have prognostic impact in several cancer types, e.g. breast-, colon-, gastric- and lung cancer. Most of these studies have used quantification by enzyme-linked immunosorbent as
Autor:
Ebbe Rønne, Nils Brünner, Keld Danø, Heine H. Hansen, Jan Grøndahl-Hansen, Gunilla Høyer-Hansen, Helle Pappot
Publikováno v:
European Journal of Cancer. 33:867-872
The urokinase plasminogen activator (uPA) is involved in extracellular matrix degradation during cancer invasion. Binding of uPA to a specific cell surface receptor (uPAR) is a key step in this process. We have previously reported that high levels of
Autor:
Torben Plesner, Ebbe Rønne, Keld Danø, Niels Ebbe Hansen, Gunilla Høyer-Hansen, Helle Pappot, Jan Grøndahl-Hansen
Publikováno v:
British Journal of Haematology. 89:576-581
The urokinase plasminogen activator (uPA) is a proteolytic enzyme which converts the proenzyme plasminogen to the active serine protease plasmin. A cell surface receptor for uPA (uPAR) is attached to the cell membrane by a glycosyl-phosphatidylinosit
Publikováno v:
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. 19(3)
Lipopolysaccharide (LPS) antigen was purified from Actinobacillus pleuropneumoniae serovar 7 by phenol-water extraction and fractionated on a, S-100 Sephacryl column. High molecular weight fractions of LPS purified from the S-100 column were pooled a
Publikováno v:
Breast cancer research and treatment. 47(1)
Prognostic factors are highly needed to divide node negative breast cancer patients into groups of low versus high risk of recurrence and death. In order to invade and spread, cancer cells must degrade extracellular matrix proteins. Accordingly, tumo
Autor:
Nils Brünner, Carle Christensen, Jan Grøndahl-Hansen, Susan G. Hilsenbeck, Gary M. Clark, C. Kent Osborne
Publikováno v:
Breast cancer research and treatment. 43(2)
Cancer cell invasion is accomplished by the concerted action of several extracellular proteolytic enzyme systems, one of which is the urokinase plasminogen activation system. The different components of this system. e.g. urokinase plasminogen activat
Autor:
Fred C.G.J. Sweep, Nils Brünner, H. de Witte, Niels Behrendt, Gunilla Høyer-Hansen, Theo Benraad, Keld Danø, Jan Grøndahl-Hansen, B Guldhammer-Skov, Helle Pappot
Publikováno v:
International Journal of Cancer, 72, pp. 416-423
International Journal of Cancer, 72, 416-423
International Journal of Cancer, 72, 3, pp. 416-423
International Journal of Cancer, 72, 416-423
International Journal of Cancer, 72, 3, pp. 416-423
A sandwich-type ELISA has been developed for the assessment of complexes between urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in extracts of squamous cell lung carcinomas. The assay is based on a combination of rabbit polyclonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::546fe7a30d8cf0e6e10084335620b1c5
https://hdl.handle.net/2066/222671
https://hdl.handle.net/2066/222671
Autor:
F. Rank, Jan Grøndahl-Hansen, Gunilla Høyer-Hansen, Keld Danø, Ebbe Rønne, Gary M. Clark, C K Osborne, Nils Brünner, Helle Pedersen
Publikováno v:
Breast cancer research and treatment. 33(3)
Urokinase plasminogen activator (uPA) is a proteolytic enzyme involved in degradation of the extracellular matrix during cancer invasion. The levels of uPA and its inhibitor PAI-1 in tumor extracts have previously been demonstrated to be of prognosti